Herve Rubie
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study.
Journal: Pediatric blood & cancer
Published: March 20, 2019
Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials.
Journal: Pediatric blood & cancer
Published: February 22, 2016
Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 20, 2015
Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: November 25, 2014
Multidisciplinarity, education, and training in pediatric oncology-hematology
Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Published: September 13, 2014
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 05, 2013
Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.
Journal: Pediatric blood & cancer
Published: February 27, 2013
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 18, 2013
The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy.
Journal: Human pathology
Published: December 17, 2012
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.
Journal: Cancer chemotherapy and pharmacology
Published: July 18, 2012
French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: June 27, 2012
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).
Journal: British journal of cancer
Published: December 08, 2011
Last Updated: 09/26/2026